Hanson wade have taken the decision to cancel this event. Please do accept our apologies for any inconvenience or disappointment this will cause. Please register your interest here if you would like updates on the conference or topic.

Connect with Disruptive Life Sciences Leaders Raising the Game in Talent Attraction & Engagement by Leveraging Agility, Flexibility & Innovation to Give Their Business a Sustainable Competitive Advantage

LEAP TA: Life Sciences is a unique open platform for the boldest TA leaders in life sciences to engage in a genuinely disruptive dialogue around how the most radical talent strategies are helping redefine work and how it’s done in an uncertain world and successfully navigate the new normal operating environment.

Taking part in this live online event helps you double click and journey into the space between reading an article and hiring a consultant to help you solve your own post-COVID recruitment challenges in the short, medium and long term.

Only at LEAP TA: Life Sciences Europe will you uncover the industry’s most forward-thinking talent acquisition leaps, including:

LEAP TA Life Sciences Europe Logo - Light (1)

Build the vital capabilities you need tomorrow, today: Find out how GSK is leveraging organisational transformation and change to meet future life sciences workforce needs

LEAP TA Life Sciences Europe Logo - Light (1)

Develop a more agile talent acquisition engine: Learn how Norgine is maximising the TA function to be able to flex and adapt in uncertain times

LEAP TA Life Sciences Europe Logo - Light (1)

Gain a competitive edge in life sciences: Hear how Sanofi is leveraging their employer brand to win the battle for talent in an ultra-competitive life sciences industry

LEAP TA Life Sciences Europe Logo - Light (1)

Take a disruptive approach to TA: Explore how Danaher is deploying next-generation talent scouting to meet the demand for quality talent

LEAP TA Life Sciences Europe Logo - Light (1)

Leverage organizational growth to boost talent engagement: Hear how Alnylam Pharmaceuticals is cultivating scalable and sustainable TA processes and keeping a strong EVP